Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Discover yearly leaders among index funds and understand how performance shifts across periods, helping you choose resilient options.
27,236 articlesA biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Blue Sage Solutions and Kinective announced a strategic partnership to streamline how community banks and credit unio...
Mercadolibre stock crashed today after investors digested a quarter that showed rising revenue but softer earnings. T...
When a beloved cartoon crew opens a real pizza spot, it’s more than a meal — it’s a lesson in money. This article exp...
A fresh rally in fintech names has traders watching carefully. This article explores why fiserv stock just popped, wh...
A new wave of proptech bundling is reshaping mortgage workflows. Real estate tech started with simplification, but to...
An AI-driven crypto benchmark echoes a cautionary tale: even with time and resources, strategic missteps can trigger ...
A CEO’s share sale at Mineralys shines a light on insider moves ahead of a key FDA event. This guide breaks down what...
A growing wave of aging business owners is approaching retirement, potentially reshaping communities. Experts say sel...
A single metric may reveal whether Nvidia will continue dominate in AI. This deep dive explains the number, the risks...
A playful sports feud could become a real money moment. This article breaks down how drew brees wants brady hints at ...
Crypto development is a high-stakes battleground for malware. This article explains how a perplexity built tool that ...